Pharmacovigilance 101: What is it and why is it important?
February 23rd, 2012
Presented by Dr. Richard Dolinar, MD
- What is pharmacovigilance
- Track & Trace systems for biologic medicines
- Coding, Naming, Labeling
- Down the Road: Interchangeability and Drug Substitution
Biosimilars 101: What are biosimilars and why should you care?
December 1st, 2011
Presented by Dr. Richard Dolinar, MD
- What are biosimilars
- Why are biosimilars not generics
- Manufacturing
- The FDA’s “biosimilar pathway”
- Policy Considerations
Biologics 101: What are biologics and why should you care?
November 17th, 2011
Presented by Alliance Chairman, Dr. Richard Dolinar, MD
- Role of biotechnology in medical advancements
- What are biologics
- Examples of biologic medicines
- Manufacturing process
- Chemical drugs vs. biologic medicines
- Implications of size, variability, complexity
- What’s next for biotechnology
